Sort by
Refine Your Search
-
employee-focused service model Offering a competitive remuneration package including 17% superannuation About the Organisation Tandem Partners is partnering with a large, complex, and purpose-led
-
statistical models and analyse disparate datasets excellent communication skills with the ability to present findings clearly to diverse audiences strong collaborator experienced working with interdisciplinary
-
therapy, proteomics, and experimental models ranging from human induced pluripotent stem cell (iPSC)-derived retinal neurons to mouse and donated human tissue. You will be part of a dynamic, collaborative
-
aspirations produce intricate financial modelling and analysis for effective decision-making identify and implement continuous improvement and new initiatives within both wider Financial Services and across
-
modelling, student mentoring, and direct collaboration with industry and university partners to ensure research outcomes are translatable and impactful. Your key responsibilities will be in: lead experimental
-
an integrated model of care for early management of individuals with moderate-to-severe traumatic brain injury (msTBI) who have pre-existing mental health difficulties. Reporting to Associate Professor, Grahame
-
level B and C minimum 3 years post-PhD experience for Level C significant experience conducting original research and engaging in scholarly activity strong analytical skills in modelling time trends and
-
Partnering team to deliver high-quality, strategic support and advice across the organisation. Build organisational capability by defining and modelling what “good partnering” looks like, driving a culture of
-
and biochemical analyses. Design, implement, and optimise in vitro and ex vivo experimental systems, including organ-on-a-chip models, to investigate retinal cell biology and disease mechanisms. Perform
-
, industry and professional partners and stakeholders doctorate of PhD in microbiology or immunology, or a related field. a developing research profile in vaccine development and infectious disease models